Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;61(1):147-157.
doi: 10.1007/s00125-017-4440-y. Epub 2017 Oct 5.

The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age

Affiliations

The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age

Jamie R J Inshaw et al. Diabetologia. 2018 Jan.

Abstract

Aims/hypothesis: The genetic risk of type 1 diabetes has been extensively studied. However, the genetic determinants of age at diagnosis (AAD) of type 1 diabetes remain relatively unexplained. Identification of AAD genes and pathways could provide insight into the earliest events in the disease process.

Methods: Using ImmunoChip data from 15,696 cases, we aimed to identify regions in the genome associated with AAD.

Results: Two regions were convincingly associated with AAD (p < 5 × 10-8): the MHC on 6p21, and 6q22.33. Fine-mapping of 6q22.33 identified two AAD-associated haplotypes in the region nearest to the genes encoding protein tyrosine phosphatase receptor kappa (PTPRK) and thymocyte-expressed molecule involved in selection (THEMIS). We examined the susceptibility to type 1 diabetes at these SNPs by performing a meta-analysis including 19,510 control participants. Although these SNPs were not associated with type 1 diabetes overall (p > 0.001), the SNP most associated with AAD, rs72975913, was associated with susceptibility to type 1 diabetes in those individuals diagnosed at less than 5 years old (p = 2.3 × 10-9).

Conclusion/interpretation: PTPRK and its neighbour THEMIS are required for early development of the thymus, which we can assume influences the initiation of autoimmunity. Non-HLA genes may only be detectable as risk factors for the disease in individuals diagnosed under the age 5 years because, after that period of immune development, their role in disease susceptibility has become redundant.

Keywords: Age at diagnosis; Early diagnosis; Genetic risk; Type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Data availability

The data analysed during the current study are available from the corresponding author on reasonable request.

Funding

CW is funded by the Wellcome Trust (WT107881) and the Medical Research Council (MC_UP_1302/5). LB was supported by the Alan Turing Institute under the EPSRC grant EP/N510129/1.

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Contribution statement

JRJI carried out statistical analyses, wrote the manuscript and approved the final version. NMW helped with acquisition of the data and preparation of the data for analysis, revised the article critically and approved the final version of the manuscript. CW provided assistance implementing GUESSFM, input into the design of the study, provided code to carry out the haplotype analysis, and revised the article critically and approved the final version of the manuscript. LB provided statistical support throughout the project to JRJI and support with interpretation of data, revised the article critically and approved the final version. JAT directed research, provided biological expertise, helped with data acquisition and study design, revised the article critically and approved the final version of the manuscript. JAT is the guarantor of this work.

Figures

Fig. 1
Fig. 1
(a) Manhattan plot from the association discovery meta-analysis for AAD of type 1 diabetes. (b) Quantile–quantile plot (excluding the MHC region). (c) Forest plot for the lead SNP in the MHC region, rs9273363. (d) Forest plot for the lead SNP in the 6q22.33 region, rs72975913
Fig. 2
Fig. 2
Output from GUESSFM fine-mapping the 6q22.33 region. (a) Location of the PTPRK and THEMIS genes, the closest genes to the candidate causal SNPs. (b) Map of the candidate causal SNPs to their physical location along chromosome 6. (c) The dots depict the strength of association (marginal posterior probability of inclusion) for each SNP, while the height of the shaded region is the gMPPI, the probability that one of the SNPs in the group is causal for AAD. It shows three signals in the region, termed groups 1 (blue), 2 (red) and 3 (green). (d) LD between SNPs
Fig. 3
Fig. 3
(a) Haplotype analysis of the 6q22.33 region with respect to the AAD of type 1 diabetes using SNPs highlighted from the GUESSFM analysis. SNPs are colour-coded according to GUESSFM group 1 (blue), 2 (red) and 3 (green). Black, major alleles; white, minor alleles. (b) Diplotype analysis of the same region. Black, major homozygotes; grey, heterozygotes; white, minor homozygotes
Fig. 4
Fig. 4
(a) Risk of type 1 diabetes (T1D) at SNPs contained in group 3 (GUESSFM analysis) rs72975913, stratified by AAD group. (b) Risk of type 1 diabetes at the SNPs contained in group 2, rs802719, stratified by AAD group. The effect size is for addition of a minor allele at the loci, assuming an additive mode of inheritance on the log-odds scale

References

    1. The Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–678. doi: 10.1038/nature05911. - DOI - PMC - PubMed
    1. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–864. doi: 10.1038/ng2068. - DOI - PMC - PubMed
    1. Barrett JC, Clayton D, Concannon P, et al. Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes. Nat Genet. 2010;41:703–707. doi: 10.1038/ng.381. - DOI - PMC - PubMed
    1. Onengut-Gumuscu S, Chen W-M, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47:381–386. doi: 10.1038/ng.3245. - DOI - PMC - PubMed
    1. Fortune MD, Guo H, Burren O, et al. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat Genet. 2015;47:839–846. doi: 10.1038/ng.3330. - DOI - PMC - PubMed